DNA Origami-Based Multivalent Nanobody Display Platform for Potent Neutralization of Botulinum Neurotoxin Type A.
TL;DR
By orderly assembling nanobodies on DNA origami, this study creates a biomimetic nanoscale trap with triple functions-"capture, enrichment, and sequestration"-against BoNT/A, which provides a highly efficient neutralization paradigm for anti-BoNT/A therapy and highlights the transformative potential of DNA origami nanostructures in reshaping protein interaction interfaces for precision medicine.
Abstract
Botulinum neurotoxins (BoNTs) are the most potent biological toxins discovered to date. Rapid capture and clearance of BoNTs from the bloodstream is a critical strategy for poisoning treatment. Nanobodies, with their high affinity, represent promising molecules for neutralizing BoNTs. Due to its small molecular weight, it has the limitation of a short half-life in the bloodstream. The BoNT/A-neutralizing nanobody, ciA-C2, binds to the receptor-binding domain of BoNT/A, blocking its interaction with the neuronal receptor SV2 and thereby preventing toxin entry into cells to achieve detoxification. This study leverages the nanoscale addressability of DNA origami technology. Through complementary base pairing, the BoNT/A-neutralizing nanobody ciA-C2 is displayed on a DNA origami nanostructure (DON), constructing a DON-ciA-C2 anti-BoNT/A system with prolonged half-life and spatially cooperative multivalency. The DON, measuring approximately 120 nm in size-about 30 times larger than ciA-C2-extends the half-life of the system due to its larger dimensions. The multivalent assembly of ciA-C2 on the DNA origami creates a "high-affinity" nanoscale surface. This design leverages dense regional proximity effects to significantly enhance toxin-binding efficiency and stability. Additionally, a physical barrier effect is formed, effectively shielding the receptor-binding domain of BoNT/A and preventing the toxin from accessing receptors on the cell membrane. In a mouse model of BoNT/A poisoning at 10 times the lethal dose (10 LD50), DON-ciA-C2 significantly improved survival rates to 100% in both prophylactic and therapeutic administration regimens. Moreover, it extended the effective half-life of ciA-C2 from 4 h to approximately 32 h. By orderly assembling nanobodies on DNA origami, this study creates a biomimetic nanoscale trap with triple functions-"capture, enrichment, and sequestration"-against BoNT/A. This strategy not only provides a highly efficient neutralization paradigm for anti-BoNT/A therapy but also highlights the transformative potential of DNA origami nanostructures in reshaping protein interaction interfaces for precision medicine.